Targeting Cancer Metabolism to Improve Outcomes with Immune Checkpoint Inhibitors

Immune checkpoint inhibitors have revolutionized the treatment paradigm of several cancers. However, not all patients respond to treatment. Tumor cells reprogram metabolic pathways to facilitate growth and proliferation. This shift in metabolic pathways creates fierce competition with immune cells f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatima, Zainab, Abonofal, Abdulrahman, Stephen, Bettzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Innovative Healthcare Institute 2023
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195018/
https://www.ncbi.nlm.nih.gov/pubmed/37214204
http://dx.doi.org/10.36401/JIPO-22-27

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195018/
https://www.ncbi.nlm.nih.gov/pubmed/37214204
http://dx.doi.org/10.36401/JIPO-22-27

Ejemplares similares